% | $
Quotes you view appear here for quick access.

VIVUS Inc. Message Board

  • vvusforme71 vvusforme71 Oct 10, 2013 10:26 PM Flag


    How can one rationalize being short or even promoting short behavior at this level? Stock is now close to 52 week low, blockbuster drug now in over 10,000 pharmacies since July, with these numbers not currently in earnings. $358 million in cash, 32$% of float short. They currently have a fund that manages the company that has no interest or experience managing a drug company, they want to sell and for much higher. They have Stendra. Drug delays progression to diabetes. Obesity likely to be classified as disease, granting insurance to reimburse for already affordable drug. Highest efficacy drug on the market. $1.2 billion projected revenue by 2020. Current market cap $1 billion, should be twice that now. downside at this level is the current price, there is no justification to be short here, other than suicide and stupidity.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
1.50-0.08(-5.06%)May 3 4:00 PMEDT